HNRNPK and acute promyelocytic leukemia: Remarkably, the selection of APL cells with shRNA for hnRNP K using a low concentration of puromycin efficiently reduced hnRNP K levels accompanied by cell death, an effect amplified mainly in NB4‐R2 cells by treatment with ATRA.